Vimarsana
Biggest News Aggregation in the World

Page 6 - Imaging Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Imaging Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Imaging Sciences Today - Breaking & Trending Today

Enroll into the UAE's best universities to secure your future today - Vimarsana News

Enroll into the UAE's best universities to secure your future today

UAE's best institutions share their fields of specialisation, new courses and more

Distinguished Service Award recipients announced | Ledger Independent – Maysville Online - Vimarsana News

Distinguished Service Award recipients announced | Ledger Independent – Maysville Online

Morehead State University has announced the recipients of the 2023 Distinguished Service Awards.

American Heart Association funds research to assess racial bias in cardiovascular treatment algorithms - Vimarsana News

American Heart Association funds research to assess racial bias in cardiovascular treatment algorithms

As part of a focused effort to assess current cardiovascular treatment algorithms for racial bias, the American Heart Association,­ the single largest non-government supporter of heart and brain health research in the U.S., is funding three new scientific research projects at $50,000 each.

Research discovers device-mimicking controller best approach for neuroradiology procedures - Vimarsana News

Research discovers device-mimicking controller best approach for neuroradiology procedures

Researchers from the School of Biomedical Engineering & Imaging Sciences, King’s College London, have found that a device-mimicking robotic controller is better suited for controlling interventional neuroradiology robotic procedures than joystick

U.S. FDA Approves Blue Earth Diagnostics' POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer - Vimarsana News

U.S. FDA Approves Blue Earth Diagnostics' POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

POSLUMA will be commercially available in the United States in early June 2023